S
Sabarish V. Indran
Researcher at Kansas State University
Publications - 23
Citations - 764
Sabarish V. Indran is an academic researcher from Kansas State University. The author has contributed to research in topics: Rift Valley fever & Protein kinase R. The author has an hindex of 13, co-authored 21 publications receiving 514 citations. Previous affiliations of Sabarish V. Indran include University of Texas System & National Institutes of Health.
Papers
More filters
Journal ArticleDOI
SARS-CoV-2 infection, disease and transmission in domestic cats.
Natasha N. Gaudreault,Jessie D. Trujillo,Mariano Carossino,David A. Meekins,Igor Morozov,Daniel W. Madden,Sabarish V. Indran,Dashzeveg Bold,Velmurugan Balaraman,Taeyong Kwon,Bianca Libanori Artiaga,Konner Cool,Adolfo García-Sastre,Wenjun Ma,William C. Wilson,Jamie Henningson,Udeni B. R. Balasuriya,Juergen A. Richt +17 more
TL;DR: The results of this study are critical for understanding the clinical course of SARS-CoV-2 in a naturally susceptible host species, and for risk assessment.
Journal ArticleDOI
Susceptibility of swine cells and domestic pigs to SARS-CoV-2
David A. Meekins,Igor Morozov,Jessie D. Trujillo,Natasha N. Gaudreault,Dashzeveg Bold,Mariano Carossino,Bianca Libanori Artiaga,Sabarish V. Indran,Taeyong Kwon,Velmurugan Balaraman,Daniel W. Madden,Heinz Feldmann,Jamie Henningson,Wenjun Ma,Wenjun Ma,Udeni B. R. Balasuriya,Juergen A. Richt +16 more
TL;DR: It is indicated that although different porcine cell lines are permissive to SARS-CoV-2, five-week old pigs are not susceptible to infection via oral/intranasal/intratracheal challenge and are not a suitable pre-clinical animal model to study Sars-Cov-2 pathogenesis or efficacy of respective vaccines or therapeutics.
Journal ArticleDOI
Bicaudal D1-Dependent Trafficking of Human Cytomegalovirus Tegument Protein pp150 in Virus-Infected Cells
TL;DR: Yeast two-hybrid analyses were utilized to detect an interaction between pp150 and Bicaudal D1 (BicD1), a protein thought to play a role in trafficking within the secretory pathway, and provided additional evidence that morphogenesis of the AC and virus assembly were dynein dependent.
Journal ArticleDOI
TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation.
Jessica Sook Yuin Ho,Bobo Wing-Yee Mok,Laura Campisi,Tristan X. Jordan,Soner Yildiz,Sreeja Parameswaran,Joseph A. Wayman,Joseph A. Wayman,Natasha N. Gaudreault,David A. Meekins,Sabarish V. Indran,Igor Morozov,Jessie D. Trujillo,Yesai Fstkchyan,Raveen Rathnasinghe,Zeyu Zhu,Simin Zheng,Nan Zhao,Kris M. White,Helen Ray-Jones,Valeriya Malysheva,Michiel J. Thiecke,Siu Ying Lau,Honglian Liu,Anna Junxia Zhang,Andrew Chak-Yiu Lee,Wen-Chun Liu,Sonia Jangra,Alba Escalera,Teresa Aydillo,Betsaida Salom Melo,Ernesto Guccione,Robert Sebra,Elaine Shum,Jan Bakker,Jan Bakker,Jan Bakker,David A. Kaufman,Andre L. Moreira,Mariano Carossino,Udeni B. R. Balasuriya,Minji Byun,Randy A. Albrecht,Michael Schotsaert,Adolfo García-Sastre,Sumit K. Chanda,Emily R. Miraldi,Emily R. Miraldi,Anand D. Jeyasekharan,Benjamin R. tenOever,Mikhail Spivakov,Matthew T. Weirauch,Matthew T. Weirauch,Sven Heinz,Honglin Chen,Christopher Benner,Juergen A. Richt,Ivan Marazzi +57 more
TL;DR: In this paper, using multidimensional epigenetic, transcriptional, in-vitro, and invivo analyses, the authors reported that topoisomerase 1 (TOP1) inhibition suppresses lethal inflammation induced by SARS-CoV-2.
Journal ArticleDOI
Novel approaches to develop Rift Valley fever vaccines
TL;DR: In this review, problems of traditional vaccines and the safety and efficacy of recently reported novel RVF candidate vaccines including subunit vaccines, virus vector, and replicons are discussed.